[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":538,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.3,"TPM_sd":22.46,"TPM_min":1.04,"TPM_25th_percentile":5.47,"TPM_median":11.71,"TPM_75th_percentile":26.09,"TPM_max":180.54},{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":75,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.89,"TPM_sd":15.25,"TPM_min":0.93,"TPM_25th_percentile":6.62,"TPM_median":14.18,"TPM_75th_percentile":28.39,"TPM_max":68.29},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":168,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.48,"TPM_sd":17.02,"TPM_min":0,"TPM_25th_percentile":5.4,"TPM_median":10.1,"TPM_75th_percentile":17.81,"TPM_max":149.86},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.46,"TPM_sd":11.04,"TPM_min":0.21,"TPM_25th_percentile":7.3,"TPM_median":10.52,"TPM_75th_percentile":18.22,"TPM_max":64.48},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 58)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":43,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.19,"TPM_sd":17.9,"TPM_min":2.37,"TPM_25th_percentile":5.73,"TPM_median":7.8,"TPM_75th_percentile":9.14,"TPM_max":118.18},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 58)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.45,"TPM_sd":2.78,"TPM_min":4.06,"TPM_25th_percentile":5.7,"TPM_median":7.03,"TPM_75th_percentile":8.43,"TPM_max":14.03},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.57,"TPM_sd":18.31,"TPM_min":2.63,"TPM_25th_percentile":4.98,"TPM_median":6.58,"TPM_75th_percentile":9.61,"TPM_max":117.84},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.28,"TPM_sd":4.52,"TPM_min":3.14,"TPM_25th_percentile":5.22,"TPM_median":6.88,"TPM_75th_percentile":9.38,"TPM_max":17.5},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.32,"TPM_sd":1.15,"TPM_min":3.45,"TPM_25th_percentile":3.46,"TPM_median":3.89,"TPM_75th_percentile":4.61,"TPM_max":6.19},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.1,"TPM_sd":2.97,"TPM_min":6.13,"TPM_25th_percentile":6.39,"TPM_median":6.66,"TPM_75th_percentile":9.09,"TPM_max":11.51},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":16.99,"TPM_sd":29.19,"TPM_min":2.68,"TPM_25th_percentile":4.77,"TPM_median":5.95,"TPM_75th_percentile":10.02,"TPM_max":97.97},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":28.52,"TPM_sd":40.07,"TPM_min":1.91,"TPM_25th_percentile":2.1,"TPM_median":7.13,"TPM_75th_percentile":35.84,"TPM_max":95.63},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.05,"TPM_sd":15.9,"TPM_min":4.96,"TPM_25th_percentile":6.99,"TPM_median":12.98,"TPM_75th_percentile":20.16,"TPM_max":52.56},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":19.02,"TPM_sd":26.04,"TPM_min":2.07,"TPM_25th_percentile":4.9,"TPM_median":9.69,"TPM_75th_percentile":18.32,"TPM_max":80.99},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.78,"TPM_sd":1.58,"TPM_min":2.01,"TPM_25th_percentile":3.52,"TPM_median":4.77,"TPM_75th_percentile":6.14,"TPM_max":7.18},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.75,"TPM_sd":2.98,"TPM_min":3.23,"TPM_25th_percentile":4.11,"TPM_median":4.98,"TPM_75th_percentile":7,"TPM_max":9.03},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 28)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":22,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":22.3,"TPM_sd":16.37,"TPM_min":7.73,"TPM_25th_percentile":10.55,"TPM_median":20.14,"TPM_75th_percentile":23.76,"TPM_max":66.85},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 28)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.86,"TPM_sd":2.73,"TPM_min":5.18,"TPM_25th_percentile":5.74,"TPM_median":7.16,"TPM_75th_percentile":9.56,"TPM_max":12.02},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.32,"TPM_sd":2.07,"TPM_min":2.31,"TPM_25th_percentile":2.88,"TPM_median":4.03,"TPM_75th_percentile":5.46,"TPM_max":6.92},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.96,"TPM_sd":1.69,"TPM_min":5.52,"TPM_25th_percentile":6.06,"TPM_median":6.43,"TPM_75th_percentile":7.04,"TPM_max":10.2},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.01,"TPM_sd":18.18,"TPM_min":0.86,"TPM_25th_percentile":5.62,"TPM_median":8.89,"TPM_75th_percentile":22.92,"TPM_max":86.15},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":48,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.95,"TPM_sd":14.18,"TPM_min":1.69,"TPM_25th_percentile":4.96,"TPM_median":6.77,"TPM_75th_percentile":9.99,"TPM_max":79.59},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.4,"TPM_sd":4.6,"TPM_min":2.95,"TPM_25th_percentile":5.81,"TPM_median":8.88,"TPM_75th_percentile":11.33,"TPM_max":23},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.15,"TPM_sd":3.17,"TPM_min":3.64,"TPM_25th_percentile":7.74,"TPM_median":10.56,"TPM_75th_percentile":10.96,"TPM_max":12.71},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.11,"TPM_sd":6.71,"TPM_min":0.36,"TPM_25th_percentile":5.27,"TPM_median":6.92,"TPM_75th_percentile":8.9,"TPM_max":58.85},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.06,"TPM_sd":2.76,"TPM_min":3.5,"TPM_25th_percentile":5.43,"TPM_median":6.24,"TPM_75th_percentile":8.25,"TPM_max":16.51},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.34,"TPM_sd":4.07,"TPM_min":4.69,"TPM_25th_percentile":7.51,"TPM_median":9.57,"TPM_75th_percentile":12.68,"TPM_max":18.7},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.28,"TPM_sd":4.08,"TPM_min":8.58,"TPM_25th_percentile":10.09,"TPM_median":11.6,"TPM_75th_percentile":14.13,"TPM_max":16.66},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.66,"TPM_sd":4.71,"TPM_min":0.95,"TPM_25th_percentile":5.34,"TPM_median":8.25,"TPM_75th_percentile":10.91,"TPM_max":25.97},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.46,"TPM_sd":3.97,"TPM_min":2.14,"TPM_25th_percentile":5.57,"TPM_median":7.57,"TPM_75th_percentile":11.87,"TPM_max":14.42},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":17,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.63,"TPM_sd":26.11,"TPM_min":2.21,"TPM_25th_percentile":5.82,"TPM_median":8.09,"TPM_75th_percentile":13.58,"TPM_max":86.91},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.04,"TPM_sd":2.73,"TPM_min":2.03,"TPM_25th_percentile":3.98,"TPM_median":6.69,"TPM_75th_percentile":8.13,"TPM_max":9.34},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 175)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":125,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.71,"TPM_sd":16.24,"TPM_min":0.95,"TPM_25th_percentile":6.11,"TPM_median":10.7,"TPM_75th_percentile":25.74,"TPM_max":81.59},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 175)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":50,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.16,"TPM_sd":7.51,"TPM_min":1.75,"TPM_25th_percentile":5.03,"TPM_median":7.31,"TPM_75th_percentile":10.58,"TPM_max":49.95},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.02,"TPM_sd":2.34,"TPM_min":2.75,"TPM_25th_percentile":6.6,"TPM_median":7.47,"TPM_75th_percentile":8.55,"TPM_max":9.18},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.45,"TPM_sd":0.86,"TPM_min":4.54,"TPM_25th_percentile":5.07,"TPM_median":5.32,"TPM_75th_percentile":5.71,"TPM_max":6.62},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 412)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":334,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.12,"TPM_sd":7.09,"TPM_min":1.27,"TPM_25th_percentile":6.04,"TPM_median":7.81,"TPM_75th_percentile":10.37,"TPM_max":88.25},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 412)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":78,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.83,"TPM_sd":4.62,"TPM_min":2.24,"TPM_25th_percentile":5.25,"TPM_median":6.8,"TPM_75th_percentile":9.22,"TPM_max":33.58},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":206,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.68,"TPM_sd":27.94,"TPM_min":1.59,"TPM_25th_percentile":8.82,"TPM_median":12.06,"TPM_75th_percentile":17.57,"TPM_max":241.56},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.99,"TPM_sd":8.41,"TPM_min":2.36,"TPM_25th_percentile":7.74,"TPM_median":10.51,"TPM_75th_percentile":13.61,"TPM_max":38.87},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.61,"TPM_sd":5.48,"TPM_min":3.16,"TPM_25th_percentile":5.04,"TPM_median":6.17,"TPM_75th_percentile":8.61,"TPM_max":33.84},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":11,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.23,"TPM_sd":2.22,"TPM_min":0.3,"TPM_25th_percentile":4,"TPM_median":5.58,"TPM_75th_percentile":6.57,"TPM_max":8.03},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":29.06,"TPM_sd":18.32,"TPM_min":2.63,"TPM_25th_percentile":13.48,"TPM_median":24.7,"TPM_75th_percentile":43.16,"TPM_max":88.29},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.31,"TPM_sd":4.72,"TPM_min":3.34,"TPM_25th_percentile":7.21,"TPM_median":10.36,"TPM_75th_percentile":12.36,"TPM_max":19.43},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.92,"TPM_sd":5.32,"TPM_min":2.63,"TPM_25th_percentile":9.29,"TPM_median":12.46,"TPM_75th_percentile":16.23,"TPM_max":26.87},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.76,"TPM_sd":4.15,"TPM_min":8.02,"TPM_25th_percentile":10.54,"TPM_median":11.94,"TPM_75th_percentile":14.48,"TPM_max":19.43},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.19,"TPM_sd":2.95,"TPM_min":1.88,"TPM_25th_percentile":3.22,"TPM_median":4.52,"TPM_75th_percentile":5.92,"TPM_max":12.81},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.34,"TPM_sd":2.46,"TPM_min":1.44,"TPM_25th_percentile":3.77,"TPM_median":6.22,"TPM_75th_percentile":6.86,"TPM_max":8.49},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 62)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":36,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.26,"TPM_sd":6.78,"TPM_min":6.48,"TPM_25th_percentile":9.19,"TPM_median":11.63,"TPM_75th_percentile":14.15,"TPM_max":36.92},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 62)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":26,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.7,"TPM_sd":4.51,"TPM_min":5.56,"TPM_25th_percentile":8.9,"TPM_median":10.2,"TPM_75th_percentile":13.77,"TPM_max":21.24},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.39,"TPM_sd":2.1,"TPM_min":3.12,"TPM_25th_percentile":5.06,"TPM_median":6.44,"TPM_75th_percentile":8.13,"TPM_max":8.8},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.45,"TPM_sd":3.84,"TPM_min":5.88,"TPM_25th_percentile":6.24,"TPM_median":6.6,"TPM_75th_percentile":9.73,"TPM_max":12.86},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":37.43,"TPM_sd":43.6,"TPM_min":3.69,"TPM_25th_percentile":7.42,"TPM_median":12.5,"TPM_75th_percentile":78.61,"TPM_max":102.03},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.01,"TPM_sd":5.38,"TPM_min":6.7,"TPM_25th_percentile":9.2,"TPM_median":10.97,"TPM_75th_percentile":13.78,"TPM_max":19.41},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.58,"TPM_sd":2.1,"TPM_min":2.58,"TPM_25th_percentile":4.04,"TPM_median":6.13,"TPM_75th_percentile":6.89,"TPM_max":8.45},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.08,"TPM_sd":2.25,"TPM_min":1.93,"TPM_25th_percentile":2.31,"TPM_median":3.32,"TPM_75th_percentile":5.5,"TPM_max":7.84},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.55,"TPM_sd":2.79,"TPM_min":3.28,"TPM_25th_percentile":4.52,"TPM_median":5.44,"TPM_75th_percentile":8.75,"TPM_max":13.09},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.27,"TPM_sd":1.94,"TPM_min":4.61,"TPM_25th_percentile":6.61,"TPM_median":7.64,"TPM_75th_percentile":8.3,"TPM_max":9.17},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.96,"TPM_sd":6.22,"TPM_min":3,"TPM_25th_percentile":5.51,"TPM_median":9.03,"TPM_75th_percentile":13.71,"TPM_max":19.09},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.76,"TPM_sd":2.08,"TPM_min":0.83,"TPM_25th_percentile":1.65,"TPM_median":2.47,"TPM_75th_percentile":3.72,"TPM_max":4.97},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":124,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.31,"TPM_sd":5.3,"TPM_min":2.45,"TPM_25th_percentile":8.68,"TPM_median":11.61,"TPM_75th_percentile":15.03,"TPM_max":34.82},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.26,"TPM_sd":5.58,"TPM_min":8.42,"TPM_25th_percentile":10.69,"TPM_median":13.4,"TPM_75th_percentile":15.9,"TPM_max":22.89}]